Hunter Associates Investment Management LLC Gilead Sciences, Inc. Transaction History
Hunter Associates Investment Management LLC
- $646 Million
- Q3 2024
A detailed history of Hunter Associates Investment Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Hunter Associates Investment Management LLC holds 17,925 shares of GILD stock, worth $1.67 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
17,925
Previous 17,725
1.13%
Holding current value
$1.67 Million
Previous $1.22 Million
23.3%
% of portfolio
0.23%
Previous 0.2%
Shares
26 transactions
Others Institutions Holding GILD
# of Institutions
1,926Shares Held
992MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.8 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.15 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.77 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.62 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $117B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...